Sunday 3 November 2013

Friday's Round Up

A little late this week....

Counterfeit Xanax uncovered

More counterfeit drugs have been seized in Zurich.  It appears to have come from China and analysis of the products showed no active ingredient in them at all.

Thalidomide Overview

A great article describing the history of this well known drug and how it has been developed into treatments for cancer and leprosy.

Imigran Recall (UK)

A class 2 recall in the UK for the migraine treatment Imigran due to protruding needles.  A good example of how medicinal products are often combined with medical devices (eg needles/syringes) for drug delivery purposes.  Defects in these devices can be as significant as those to the drug itself so you need to be aware of the relevant functional testing of the finished product and delivery systems.

Paracetamol Suspension Recall (USA)

Another example of how a defect in a co-packaged medical device leads to a product recall.   The risk of overdose in paracetamol without graduated syringe markers is severe, hence the recall.  What would be your actions if this product was life critical with no alternatives?

Novomix Insulin Recall (UK)

A class 2 recall issued due to potential for variance in fill levels of insulin cartridges.  The drug alert is very comprehensive and provides detailed information for both patients and clinicians with regards to this recall. 



Happy Reading!












No comments:

Post a Comment